Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tivantinib + Carboplatin + Pemetrexed in Advanced Cancer
NCT02049060Phase 2Completed
- Sponsor
- Armando Santoro
- Start
- Jan 2013
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tivantinib in malignant pleural mesothelioma (MPM), Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC), sponsored by Armando Santoro. Started Jan 2013; status: completed.
02
Drugs
tivantinib
03
Conditions
malignant pleural mesothelioma (MPM)Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC)
Beyond the preview
Go deeper on NCT02049060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02049060.